Comment on "Compromised birth outcomes and infant mortality among racial and ethnic groups"

W J van der Veen1

  • 1Population Research Centre, University of Groningen, The Netherlands. w.j.van.der.veen@frw.rug.nl

Demography
|December 16, 1998
PubMed

Insights

Analyzing racial and ethnic disparities in infant mortality requires accounting for low birth weight and preterm delivery. Frisbie et al.’s method for intrauterine growth-retardation is flawed for population-level studies.

Area of Science:

  • Perinatal epidemiology
  • Public health research
  • Biostatistics

Background:

  • Previous research highlighted the importance of considering low birth weight, preterm delivery, and intrauterine growth-retardation (IUGR) in analyzing birth outcomes and infant mortality across racial and ethnic groups.
  • Discrepancies exist between fetal growth curves used by Frisbie et al. (1996) and those commonly applied in obstetric and pediatric fields.

Purpose of the Study:

  • To compare findings on birth outcomes and infant mortality between the 1987 and 1988 U.S. birth cohorts.
  • To critically evaluate the fetal growth curve calculations by Frisbie et al. and their suitability for population-level IUGR studies.
  • To propose an alternative method for assessing normal intrauterine growth using vital statistics data.

Main Methods:

  • Utilized linked birth and infant death vital statistics data from the National Center for Health Statistics for the 1987 and 1988 U.S. birth cohorts.
  • Compared birth outcome distributions and infant death probabilities using Frisbie et al.'s methodology against other established standards.
  • Examined the accuracy of gestational age measurement in the utilized vital statistics data.

Main Results:

  • Frisbie et al.'s method for assessing intrauterine growth-retardation demonstrated significant limitations when applied at the population level.
  • Major flaws were identified in the measurement of gestational age within the vital statistics data used by Frisbie et al.
  • The study found that Frisbie et al.'s fetal growth curves were inconsistent with commonly accepted obstetric and pediatric standards.

Conclusions:

  • The methodology proposed by Frisbie et al. is not appropriate for population-level studies of intrauterine growth-retardation due to data limitations, particularly in gestational age measurement.
  • An alternative approach involving the application of a standard for normal intrauterine growth, derived from antenatal estimation of fetal weight-for-gestational-age, is recommended for vital statistics data.
  • Accurate assessment of intrauterine growth-retardation requires robust gestational age estimation and appropriate growth curve standards for reliable public health research.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...